Literature DB >> 21386140

Modeling late rectal toxicities based on a parameterized representation of the 3D dose distribution.

Florian Buettner1, Sarah L Gulliford, Steve Webb, Mike Partridge.   

Abstract

Many models exist for predicting toxicities based on dose-volume histograms (DVHs) or dose-surface histograms (DSHs). This approach has several drawbacks as firstly the reduction of the dose distribution to a histogram results in the loss of spatial information and secondly the bins of the histograms are highly correlated with each other. Furthermore, some of the complex nonlinear models proposed in the past lack a direct physical interpretation and the ability to predict probabilities rather than binary outcomes. We propose a parameterized representation of the 3D distribution of the dose to the rectal wall which explicitly includes geometrical information in the form of the eccentricity of the dose distribution as well as its lateral and longitudinal extent. We use a nonlinear kernel-based probabilistic model to predict late rectal toxicity based on the parameterized dose distribution and assessed its predictive power using data from the MRC RT01 trial (ISCTRN 47772397). The endpoints under consideration were rectal bleeding, loose stools, and a global toxicity score. We extract simple rules identifying 3D dose patterns related to a specifically low risk of complication. Normal tissue complication probability (NTCP) models based on parameterized representations of geometrical and volumetric measures resulted in areas under the curve (AUCs) of 0.66, 0.63 and 0.67 for predicting rectal bleeding, loose stools and global toxicity, respectively. In comparison, NTCP models based on standard DVHs performed worse and resulted in AUCs of 0.59 for all three endpoints. In conclusion, we have presented low-dimensional, interpretable and nonlinear NTCP models based on the parameterized representation of the dose to the rectal wall. These models had a higher predictive power than models based on standard DVHs and their low dimensionality allowed for the identification of 3D dose patterns related to a low risk of complication.

Entities:  

Mesh:

Year:  2011        PMID: 21386140     DOI: 10.1088/0031-9155/56/7/013

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  9 in total

1.  Tensor Regression-based Model to Investigate Heterogeneous Spatial Radiosensitivity After I-125 Seed Implantation for Prostate Cancer.

Authors:  Kazuma Kobayashi; Naoya Murakami; Kana Takahashi; Koji Inaba; Hiroshi Igaki; Ryuji Hamamoto; Jun Itami
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  Detecting spatial susceptibility to cardiac toxicity of radiation therapy for lung cancer.

Authors:  Xiaonan Liu; Mirek Fatyga; Steven E Schild; Jing Li
Journal:  IISE Trans Healthc Syst Eng       Date:  2020-07-22

3.  Voxel-based population analysis for correlating local dose and rectal toxicity in prostate cancer radiotherapy.

Authors:  Oscar Acosta; Gael Drean; Juan D Ospina; Antoine Simon; Pascal Haigron; Caroline Lafond; Renaud de Crevoisier
Journal:  Phys Med Biol       Date:  2013-03-26       Impact factor: 3.609

4.  A tensor-based population value decomposition to explain rectal toxicity after prostate cancer radiotherapy.

Authors:  Juan David Ospina; Frédéric Commandeur; Richard Ríos; Gaël Dréan; Juan Carlos Correa; Antoine Simon; Pascal Haigron; Renaud de Crevoisier; Oscar Acosta
Journal:  Med Image Comput Comput Assist Interv       Date:  2013

5.  Spatial rectal dose/volume metrics predict patient-reported gastro-intestinal symptoms after radiotherapy for prostate cancer.

Authors:  Oscar Casares-Magaz; Ludvig Paul Muren; Vitali Moiseenko; Stine E Petersen; Niclas Johan Pettersson; Morten Høyer; Joseph O Deasy; Maria Thor
Journal:  Acta Oncol       Date:  2017-09-08       Impact factor: 4.089

6.  Parametrized rectal dose and associations with late toxicity in prostate cancer radiotherapy.

Authors:  Lynsey J Hamlett; Andrew J McPartlin; Edward J Maile; Gareth Webster; Ric Swindell; Carl G Rowbottom; Ananya Choudhury; Adam H Aitkenhead
Journal:  Br J Radiol       Date:  2015-08-06       Impact factor: 3.039

7.  Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy.

Authors:  L E A Shelley; J E Scaife; M Romanchikova; K Harrison; J R Forman; A M Bates; D J Noble; R Jena; M A Parker; M P F Sutcliffe; S J Thomas; N G Burnet
Journal:  Radiother Oncol       Date:  2017-04-28       Impact factor: 6.280

8.  Investigating rectal toxicity associated dosimetric features with deformable accumulated rectal surface dose maps for cervical cancer radiotherapy.

Authors:  Jiawei Chen; Haibin Chen; Zichun Zhong; Zhuoyu Wang; Brian Hrycushko; Linghong Zhou; Steve Jiang; Kevin Albuquerque; Xuejun Gu; Xin Zhen
Journal:  Radiat Oncol       Date:  2018-07-06       Impact factor: 3.481

9.  Ano-rectal wall dose-surface maps localize the dosimetric benefit of hydrogel rectum spacers in prostate cancer radiotherapy.

Authors:  Ben G L Vanneste; Florian Buettner; Michael Pinkawa; Philippe Lambin; Aswin L Hoffmann
Journal:  Clin Transl Radiat Oncol       Date:  2018-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.